Grounded in precision.
Guided by care.

Grounded in precision. Guided by care.

Grounded in precision.
Guided by care.

Ultrasound AI builds clinically validated technology that supports healthcare providers with clearer insight during pregnancy, for the moments when it matters most

Founded on innovation, driven by purpose

Built by technologists and clinicians

Experience in AI, data science, and software engineering

Turning complex imaging data into clear, clinically useful insights

“Every family deserves clarity and confidence during pregnancy.”

Robert Bunn
President & Founder

Our values in practice

Our values guide how we build, partner, and show up for clinicians and families every day.

Innovation

Thoughtfully built AI that brings calm clarity to prenatal ultrasound.

Collaboration

Bringing clinical and technical expertise together to advance maternal care.

Excellence

Designed with precision and care, grounded in clinical evidence and built to earn the trust of clinicians who rely on it.

Built on science you can trust.

Ultrasound AI combines patented technology with large-scale clinical data to deliver insights clinicians can rely on.

Patented AI technologies designed specifically for prenatal ultrasound analysis

Delivery Date AI™ developed to support more informed clinical decisions in suboptimally dated pregnancies

Trained on over 2 million ultrasound images to ensure robustness across diverse populations

Clarity for clinicians. Confidence for families.

Leadership Team & Advisors

in

Robert Bunn

Founder & President of Ultrasound AI

in

Michael S. Davis

Chief Executive Officer

in

Andrew Newhouse

Chief Operating Officer & General Counsel

in

Dr. Raquel Dardik

Chief Medical Officer, Board-certified OB/GYN

in

Jeannette Skinner

Strategic Advisor, RN, MBA, FACHE

Dr. Rodrigo Alliende

Strategic Advisor, Chile, Gynecologic Oncologist

in

Dr. Narendra Kini

Strategic Advisor, Emergency Medicine Physician

Leadership Team and Advisors

Robert Bunn

Founder & President

Dr. Raquel Dardik

Chief Medical Officer

Michael S. Davis

Chief Executive Officer

Andrew Newhouse

Chief Operating Officer

Jeannette Skinner

Strategic Advisor

Dr. Rodrigo Alliende

Strategic Advisor, Gynecologic Oncologist

Dr. Narendra Kini

Strategic Advisor, Emergency Medicine Physician

Board of directors

Greg Fortunoff

Chair & Director

Justin Bellante

Director

Tina Vidal

Director

Paul Farnsworth

Director

Key milestones

Our journey from personal mission to delivery dating.

2017

From oil to ultrasound

Before founding Ultrasound AI, Robert Bunn built AI systems and applied machine learning to oil and gas exploration. When that industry contracted, he turned the same expertise toward something far more personal.

2019

A personal mission becomes a company

After a personal loss, Robert Bunn founded Ultrasound AI with a conviction that better technology for pregnancy dating was possible.

2021

Delivery Date AI takes shape

The first working model is trained using AI applied to ultrasound imaging.

2022

First patent issued

2023

Geneva Innovation Award

Recognized internationally for innovation and clinical impact in prenatal care.

2024

Independent clinical validation

The PAIR study at the University of Kentucky validates the model across 5,714 patients.

2025

Global expansion

Delivery Date AI becomes available in Brazil and Chile.

2026

FDA De Novo Granted

Featured News & Media

View all news and media

Apr 15, 2026

The Science Behind the Mission: Robert Bunn on The Healthtech Podcast

The Healthtech Podcast spoke with our founder Robert Bunn about what AI discovered in standard ultrasound images and what it means to bring predictive prenatal care to every woman on earth.

April 9, 2026

Our Founder Robert Bunn Shares the Story Behind Delivery Date AI™ with CBS News Colorado

CBS News Colorado sat down with our founder Robert Bunn to explore the personal story behind Delivery Date AI™ and what it means to bring earlier signal to clinicians caring for pregnant families.

March 3, 2026

Ultrasound AI Receives FDA De Novo Designation for AI-Powered Delivery Date Prediction

The U.S. Food and Drug Administration granted De Novo designation for Delivery Date AI™, marking a significant milestone for AI-powered delivery date prediction in prenatal care.